Send us Feedback

High Yield Plus Fund (HYP)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Lancet Publishes SELECT Study of Biogen's Daclizumab HYP, Biogen Says 150MG, 300MG DAC HYP Injections Met Endpoint
Benzinga  Apr 4  Comment 
Today Biogen Idec (NASDAQ: BIIB) announced that results from the daclizumab high-yield process (DAC HYP) SELECT clinical trial have been published as an online article in The Lancet. SELECT was a Phase 2b study designed to determine the efficacy...
Biogen (BIIB), Abbott (ABT) Report DAC HYP Met Primary Endpoint in SELECT Trial
StreetInsider.com  Oct 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Biogen+%28BIIB%29%2C+Abbott+%28ABT%29+Report+DAC+HYP+Met+Primary+Endpoint+in+SELECT+Trial/6875579.html for the full story.
[$] MS Drug Shows Effectiveness
Wall Street Journal  Aug 9  Comment 
Biogen Idec and Abbott reported positive data from experimental once-monthly multiple sclerosis drug.
Hawaiian Telcom Yellow Pages Challenges Oahu Residents to Use the Best, Recycle the Rest
Marketwire  Jan 14  Comment 
HONOLULU, HI -- (Marketwire) -- 01/14/10 -- Hawaiian Telcom Yellow Pages is once again challenging Oahu residents to Think Yellow, Go Green (TYGG) to reduce their carbon footprint. Friday, Jan. 15, 2010, marks the kickoff of the annual yellow pages




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/High_Yield_Plus_Fund_(HYP)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki